Press Releases
Nov 17, 2021

The Astellas Global Health Foundation ("Foundation") announced today it will provide $1.85 million in combined new grants to five charitable organizations for urgent projects helping improve...

Nov 3, 2021

Astellas Venture Management LLC (President: Kazunori Maruyama, Ph.D., "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and LabCentral, a launchpad for early-stage...

Oct 12, 2021

Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced that patient enrollment was completed in Cohort K of the phase...

EXPLORE ALL US PRESS RELEASES

Articles
Nov 16, 2021

Astellas was recognized in Seramount’s 2021 Top 75 Companies for Executive Women list. Seramount announced its annual list of the 2021 Top 75 Companies for Executive Women and has included...

Nov 2, 2021

Clinical trials are a crucial step in drug development to find out if an experimental treatment is safe and effective in treating a specific condition or disease. But clinical trials also trigger...

Oct 27, 2021

National Disability Employment Awareness Month is observed in the United States every October to recognize the workplace accomplishments of people living with disabilities and to reaffirm our...

EXPLORE ALL ARTICLES

Stay Connected

Get only the email alerts you want.

Subscribe

Media Contacts

corporate.communications@astellas.com

800-888-7704
(press menu option 5, then option 2)
This line is monitored between 8:00am-4:30-pm Central Time M-F

For inquiries during non-business hours, please contact us

 

Astellas on Twitter
Download Fact Sheet
Sustainability
Investors
Explore U.S. Products